MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $100,342,000 | -25.2% | 902,601 | -20.1% | 3.87% | -27.9% |
| Q3 2020 | $134,159,000 | -1.1% | 1,129,948 | -5.7% | 5.37% | -5.5% |
| Q2 2020 | $135,660,000 | +44.9% | 1,197,884 | -14.6% | 5.68% | +42.0% |
| Q1 2020 | $93,614,000 | -5.6% | 1,402,250 | +28.8% | 4.00% | +13.1% |
| Q4 2019 | $99,156,000 | +11.5% | 1,088,310 | +5.5% | 3.54% | +5.2% |
| Q3 2019 | $88,912,000 | -17.8% | 1,031,220 | -0.1% | 3.36% | -19.9% |
| Q2 2019 | $108,192,000 | -3.2% | 1,032,270 | +15.7% | 4.20% | -7.0% |
| Q1 2019 | $111,731,000 | +43.9% | 891,990 | +29.5% | 4.51% | +86.0% |
| Q4 2018 | $77,652,000 | +38.0% | 688,890 | +162.1% | 2.43% | +30.0% |
| Q3 2018 | $56,286,000 | +2.0% | 262,860 | +33.2% | 1.87% | +6.6% |
| Q2 2018 | $55,178,000 | – | 197,281 | – | 1.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 25,070 | $2,825,000 | 3.32% |
| HealthCor Management, L.P. | 688,890 | $77,652,000 | 2.43% |
| Avoro Capital Advisors LLC | 225,000 | $25,362,000 | 1.52% |
| EMORY UNIVERSITY | 17,038 | $1,921,000 | 1.51% |
| Rock Springs Capital Management LP | 241,000 | $27,166,000 | 1.28% |
| Baker Brothers Advisors | 1,169,278 | $131,801,000 | 1.08% |
| Caption Management, LLC | 100,800 | $11,362,000 | 0.91% |
| SHIKIAR ASSET MANAGEMENT INC | 14,341 | $1,617,000 | 0.84% |
| Pier Capital, LLC | 37,654 | $4,244,000 | 0.84% |
| Atika Capital Management LLC | 20,000 | $2,254,000 | 0.66% |